HL7 Standards Soon to be Free of Charge

HL7Health Level Seven® International (HL7®), the global leader in developing interoperability standards for healthcare IT, announced its decision to make much of its intellectual property (IP), including standards, freely available under licensing terms. The landmark decision represents HL7's commitment to the betterment of healthcare worldwide by ensuring that all stakeholders have equal access to its HIT standards. The new policy is expected to take effect in the first quarter of 2013.

"HL7's vision is to make its collaborative, consensus-driven standards the best and most widely used in healthcare," said Charles Jaffe, MD, PhD, CEO of HL7. "By eliminating this barrier to implementation, we can come closer to realizing our goal, in which healthcare IT can reduce costs and improve the quality of care. Coupled with increasing government demand for standards that do not require a licensing fee, our decision to move toward free standards is perfectly aligned. To this end, we have already received enthusiastic support for this decision from key healthcare stakeholders."

"This announcement is the most significant standards development in the past decade, said John Halamka, MD, MS, Chief Information Officer of the Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. "It ensures that every stakeholder will have ready access to the content standards they need for Meaningful Use. Enormous thanks to everyone who worked on this effort."

The volunteer-created standards and other select pieces of intellectual property will be made available to the international healthcare community after a period of careful analysis and planning by HL7, expected to take several months. In the interim, the traditional IP/membership model which includes access to, and the right to use HL7 standards, will continue to be in effect. Following completion of the analysis, HL7 expects to transition directly to a model in which use of HL7 standards and select IP is independent of HL7 membership. HL7 will continue to consult with its members to make their investment more valuable, and will seek their input to make this transition seamless and reflective of member needs.

"The IP from HL7 is crucial to achieving interoperability among healthcare providers," said Christopher G. Chute, MD, DrPH, Chair, ISO TC215 on Health Informatics. "It enables efficient and effective care across multidisciplinary teams that increasingly are the norm for healthcare. HL7's decision to make these resources effectively a public good is hugely welcome and will accelerate their value to society and patients everywhere. HL7 now more than ever deserves support and membership from the broader health community to ensure these resource remain state-of-the-art and freely available."

More information on HL7 membership and standards is available at www.hl7.org.

About Health Level Seven (HL7) International
Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a nonprofit, ANSI-accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...